Advertisement
CORRESPONDENCE|Articles in Press

Utility of colon allograft biopsies in surveillance of patients with small intestinal transplantation

      To the Editor,
      Mortality following small intestinal transplantation remains one of the highest among all solid organ recipients.
      • Lauro A.
      • Panaro F.
      • Iyer K.R.
      An overview of EU and USA intestinal transplant current activity.
      Inclusion of the right colon and the ileo-caecal valve with the small intestinal graft confers significant clinical and survival advantages, possibly by enhancing gut function through better fluid absorption and uptake of free fatty acids.
      • Grant D.
      • Abu-Elmagd K.
      • Mazariegos G.
      • et al.
      Intestinal transplant registry report: global activity and trends.
      Therefore, since 2000, there has been a six-fold increase in and including a segment of the colon, and currently 30% of small intestinal grafts include a colonic segment.
      • Lauro A.
      • Panaro F.
      • Iyer K.R.
      An overview of EU and USA intestinal transplant current activity.
      Colon allografts are often biopsied, either when the patient is symptomatic, or as part of surveillance endoscopies. However, experience in interpretation of colon allograft biopsies is limited and the significance of histological findings, especially in surveillance biopsies, is uncertain. We performed a systematic review of all colon allograft mucosal biopsies obtained during surveillance endoscopies and correlated histological findings with endoscopic and microbiology data. In particular, we were interested in the significance of apoptosis and cryptitis in these biopsies, and the utility of surveillance biopsies in clinical practice.
      Following approval by the Institutional Review Board, the transplantation database was used to identify patients with small intestinal or multi-visceral allografts that included a segment of colon. The pathology database was then queried to identify biopsies of colonic allografts from these patients. All colonic biopsies were reviewed blinded to clinical presentation, endoscopic findings, microbiology studies and clinical outcomes. Biopsies from second transplantations (re-transplantations) were excluded. For each biopsy, we recorded cryptitis, apoptotic activity (<6 or ≥6 per 10 consecutive crypts), crypt architectural distortion, and inflammatory infiltrate in the lamina propria. Microbiology data from within a week before or after the biopsy, including results of bacterial and viral cultures, detection of Clostridioides difficile toxin and viral loads, were recorded. Endoscopic and microbiological data were correlated with histology findings of each biopsy (Fig. 1).
      There were 116 colon biopsies from 28 patients, 17 females and 11 males (Table 1) ranging from 21–62 years of age. The indications for transplantation included mesenteric vein thrombosis (n=8), refractory/fistulising Crohn disease (n=6), abdominal tumors (n=6), and miscellaneous conditions causing insufficient small intestinal function (n=7). Eighty-five were histologically normal (NA. 1), whereas 31 showed histological findings in the form of apoptosis (n=18), focal cryptitis (n=10), chronic inflammation in lamina propria (n=5), crypt architectural distortion (n=4) and ulceration with fibrinopurulent exudate (n=1), which represented an anastomotic ulcer (Table 1). Of the biopsies with apoptosis, all except one showed <6 apoptotic bodies per 10 crypts (Fig. 2). The one biopsy with >6 apoptotic bodies per 10 crypts additionally showed crypt architectural distortion with crypt loss; there was a concurrent urine culture positive for Escherichia coli, and blood and urine cultures 2 months earlier had also been positive for E. coli. Nineteen paired small intestinal biopsies were present; these either showed findings concurrent with those in the colon, or no pathological abnormality.
      Table 1Clinicopathological correlation of 31 biopsies with histological findings
      Patient IDAge/GenderIndication for transplantColon allograft biopsy findingsPaired small intestinal biopsy findingsColonoscopy findingsMicrobiology resultsClinical symptomsClinical managementPathology report of subsequent biopsyDays between biopsies
      256 FMesenteric vein thrombosis<6 apoptosis per 10 cryptsNANormal, healthy appearing mucosaNone or negativeFollow-up surveillanceNo change in base line medicationsNo significant pathological change9
      438 FRefractory/fistulising Crohn's disease<6 apoptosis per 10 cryptsNANormal, healthy appearing mucosaNone or negativeFollow-up surveillanceNo change in base line medicationsNo significant pathological change49
      723 FGastroparesis and intestinal pseudo- obstruction<6 apoptosis per 10 crypts<6 apoptosis per 10 cryptsNormal, healthy appearing mucosaNone or negativeNausea and vomiting and abdominal painNo change in base line medicationsNo significant pathological change13
      861 MAbdominal tumour<6 apoptosis per 10 crypts<6 apoptosis per 10 cryptsUlcer in ascending colonNone or negativeFollow-up surveillanceViral culture was negative, no change in medicationsNegative for acute cellular rejection61
      937 MAbdominal tumourMild cryptitis, chronic inflammation in lamina propria<6 apoptosis per 10 cryptsMild granularity in entire examined colonNone or negativeFollow-up surveillanceNo change in base line medicationsNo significant pathological change46
      1139 MAbdominal catastrophe following duodenal switch surgery for morbid obesity<6 apoptosis per 10 cryptsNo significant pathological changeNormal, healthy appearing mucosaNone or negativeFollow-up surveillance, post-operative assessmentMore frequent screening, with no change in medicationsNo significant pathological change112
      1257 MMesenteric vein thrombosis<6 apoptosis per 10 cryptsNo significant pathological changeNormal, healthy appearing mucosaNone or negativeFollow-up surveillance, post-operative assessmentNo change in medicationsNo significant pathological change35
      1355 FRefractory/fistulising Crohn's diseaseMild cryptitis, <6 apoptosis per 10 crypts, architectural distortionNANormal, healthy appearing mucosaStool culture: postive for C. difficileAbdominal painHospitalised, increased dose of immunosuppresors, broad spectrum antibiotics, IV fluidsCrypt apoptosis, indeterminate for acute cellular rejection18
      Chronic inflammation in lamina propria, architectural distortionNAErythematous mucosaBlood culture: coagulase- negative staphylococciAbdominal painFurther increase in the dose of immunosuppresorsCrypt apoptosis and confluent crypt loss present, viral inclusions6
      1544 MMesenteric vein thrombosis<6 apoptosis per 10 crypts<6 apoptosis per 10 cryptsNormal, healthy appearing mucosaNone or negativeDark brown to black coloured stools for one weekOffered tacrolimus and dose of prednisone was increased, CMV cultures orderedNo significant pathological change74
      <6 apoptosis per 10 cryptsNo significant pathological changeNormal, healthy appearing mucosaNone or negativeFollow-up surveillanceNo change in base line medicationsNo evidence for acute cellular rejection205
      1721 MMesenteric vein thrombosisUlceration and fibrinopurulent exudateNo signifcant pathological changePoor prep, anastomotic site, friable, ulcerated, erythematousNone or negativeFollow-up surveillanceLost follow upNANA
      1826 FMesenteric vein thrombosis<6 apoptosis per 10 crypts<6 apoptosis per 10 cryptsNormal, healthy appearing mucosaNone or negativeFollow-up surveillanceNo change in base line medicationsNo evidence of acute cellular rejection65
      Chronic inflammation in lamina propria, architectural distortionNo significant pathological changeNormal, healthy appearing mucosaNone or negativeFollow-up surveillanceCulture was ordered, no change in base line medicationsNo significant pathological change91
      1962 FShort bowel syndrome<6 apoptosis per 10 cryptsNo significant pathological changeNormal, healthy appearing mucosaNone or negativeChronic diarrhoeaContinue follow-upNo significant pathological change219
      2043 FRefractory/fistulising Crohn's diseaseMild cryptitis, chronic inflammation in lamina propriaNANormal, healthy appearing mucosaBlood culture: Stenotrophomonas maltophila.

      Urine culture: C. glabrata
      Follow-up surveillanceNo change in base line medications, antibiotics for UTINo significant pathological change27
      Mild cryptitisNANormal, healthy appearing mucosaUrine culture: vancomycin- resistant enterococciFollow-up surveillanceNo change in base line medicationsNegative for acute rejection, acute inflammation or viral inclusion29
      <6 apoptosis per 10 cryptsNANormal, healthy appearing mucosaNone or negativeFollow-up surveillanceNo change in base line medicationsNo significant pathological change11
      <6 apoptosis per 10 cryptsNAAreas of mild inflammationNone or negativeFollow-up surveillanceNo change in base line medicationsMinimal non-specific changes, indeterminate for acute cellular rejection6
      2123 FAbdominal tumourMild cryptisisNAEythematous, villi suggestive of recoveryNone or negativeAbdominal pain and nausea, and one day of bloodOffered tacrolimus and dose of prednisone was increased, CMV cultures ordered, hospitalised and received IV fluidsGranulation tissue with acute and chronic inflammation18
      Mild cryptitisNANormal, healthy appearing mucosaNone or negativeFollow-up surveillanceNo change in base line medicationsNo significant pathological change. No acute rejection or viral inclusions14
      2443 FRefractory/fistulising Crohn's diseaseChronic inflammation in lamina propriaNo significant pathological changeNormal, healthy appearing mucosaNone or negativeFollow-up surveillanceTreated with probiotics without any changes to immunosuppressionSevere acute colitis with crypt injury, crypt dropout88
      Mild acute cryptisisNo significant pathological changeNormal, healthy appearing mucosaNone or negativeFollow-up surveillanceNo change in base line medicationsFocal acute colitis186
      <6 apoptosis per 10 cryptsNo significant pathological changeNormal, healthy appearing mucosaNone or negativeAbdominal pain, shingles rashOffered prograf and cellcept 1000 mgNo significant pathological change154
      Mild cryptitisMild acute enteritisNormal, healthy appearing mucosaNone or negativeFollow-up surveillanceNo change in base line medicationsNo significant pathological change31
      2560 MMesenteric vein thrombosis>6 apoptosis per 10 cryptsNo significant pathological changeNormal, healthy appearing mucosaBlood and urine culture: E. coliFollow-up surveillance, post- operative assessmentReceived high dose steroidsModerate acute cellular rejection16
      <6 apoptosis per 10 cryptsNo significant pathological changeNormal, healthy appearing mucosaNone or negativeFollow-up surveillance, post-operative assessmentNo change in base line medicationsRare crypt apoptosis (1/10 crypts), indeterminate for acute cellular rejection. Negative for viral inclusions79
      2649 MAbdominal tumourMild cryptisisNo significant pathological changeNormal, healthy appearing mucosaNone or negativeFollow-up surveillance, post-operative assessmentNo change in base line medicationsNo significant pathological change414
      2723 MCrush injury<6 apoptosis per 10 crypts, architectural distortionNACongested mucosaPositive CMV DNAAbdominal painIV ganciclovir for CMV+ test. No other change in medicationGraft rejection and retransplant12
      2860 FCirrhosis and portal vein thrombosisMild cryptitisNANormal, healthy appearing mucosaNone or negativeNANANo significant pathological change168
      <6 apoptosis per 10 crypts<6 apoptotis per 10 cryptsNormal, healthy appearing mucosaNone or negativeFollow-up surveillance, post-operative assessmentNo change in base line medicationsFocal acute colitis63
      CMV, cytomegalovirus; NA, not available; UTI, urinary tract infection.
      Fig. 1
      Fig. 1Venn diagram showing the correlation between normal and abnormal histological with normal and abnormal endoscopic findings.
      Fig. 2
      Fig. 2Colonic mucosa showing presence of apoptotic bodies in the absence of inflammatory infiltrate or reactive crypt epithelial changes.
      Of the biopsies with cryptitis, three were associated with evidence of concurrent infection. One was associated with C. difficile toxin in the stool; this biopsy also showed apoptosis (<6 per 10 crypts). The second biopsy with cryptitis had concurrent positive cultures for stenotrophomonas in blood and Candida glabrata in urine. The third biopsy was associated with positive urine culture for vancomycin resistant enterococcus. The remaining biopsies with cryptitis did not have concurrent infections or positive cultures.
      Twenty-three biopsies were associated with positive cultures, either in blood (n=6), urine (n=14) or wound/peritoneum (n=6). Of these, five were associated with abnormal endoscopies and six with abnormal histology, whereas 10 biopsies had no abnormal endoscopic or histological findings in the colon (Fig. 1). The abnormal endoscopic findings comprised congested or erythematous mucosa in four instances and a mildly altered vascular pattern in the fifth. The histological findings comprised cryptitis in three biopsies, one of which also showed 1–2 apoptosis in 10 crypts. An additional two cases showed mild non-specific crypt architectural distortion and one of these two had <6 apoptotic bodies per 10 crypts (patient with CMV DNA in blood). The sixth biopsy showed >6 apoptotic bodies per 10 crypts and mild crypt architectural distortion.
      Of 11 biopsies with abnormal endoscopic findings, (erythema, congestion, ulceration), four biopsies had no pathologic findings, four had <6 apoptotic bodies per 10 crypts, two had focal cryptitis and one confirmed an anastomotic ulcer noted on endoscopy(Fig. 1).
      There were 59 paired small intestinal biopsies; seven were histologically abnormal, six showed rare apoptosis and one, focal cryptitis. The corresponding colonic biopsies showed similar findings in the form of rare apoptosis and/or focal cryptitis.
      Inclusion of a small segment of colon in continuity with small intestinal allograft leads to better outcomes, both in terms of small intestinal function as well as graft survival. In our institution, we receive numerous biopsies of the colon allograft from ‘surveillance’ endoscopies. Most of these are histologically normal, but they are interspersed with biopsies that show mild histological changes, which are of uncertain clinical significance. Because experience of, and literature on colon allograft biopsies is not extensive, we undertook a review of all colon allograft biopsies obtained during surveillance procedures over a 4-year period to document histological findings, and elucidate correlations, if any, with endoscopic and microbiological findings.
      The most common findings in this series were apoptosis and cryptitis. In the context of small intestinal transplantation, ≥6 apoptotic bodies per 10 crypts, along with inflammatory infiltrate in the lamina propria and crypt regenerative changes, is considered diagnostic of rejection.
      • Ruiz P.
      • Bagni A.
      • Brown R.
      • et al.
      Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium.
      ,
      • Wu T.
      • Abu-Elmagd K.
      • Bond G.
      • Nalesnik M.A.
      • Randhawa P.
      • Demetris A.J.
      A schema for histologic grading of small intestine allograft acute rejection.
      However, apoptosis may also be seen in bacterial and viral infections and are particularly well documented in CMV infection. Most often, there is accompanying acute cryptitis, but this feature may not always be present in an immunocompromised patient. Therefore, apoptosis in intestinal allograft biopsies induces uncertainty, not to mention significant anxiety, especially in colon allograft biopsies for which clear diagnostic guidelines do not exist, and diagnostic criteria are extrapolated from small intestinal allograft pathology.
      We found that as in the small intestine, isolated apoptosis in the absence of additional histological findings have no clinical significance; these patients were not treated for rejection. Although not causal, one biopsy with >6 apoptotic bodies in 10 crypts was associated with positive E. coli cultures in blood and urine over a few months. The second most common finding of focal cryptitis was not associated with concurrent infection in the majority of patients; rare patients had positive cultures in urine/stool/blood around the time of the biopsy. Conversely, of the 23 events with positive cultures in blood, urine, skin or peritoneal fluid, histological changes (all mild) were seen in only six corresponding biopsies. Concurrent small intestinal biopsies, present in approximately 50% of cases, did not demonstrate discordant findings that altered the clinical management of the patient. Similarly, a study of 51 paired biopsies from 15 patients showed concordance between small intestinal and colonic biopsies; it is uncertain if these biopsies were obtained during surveillance procedures.
      • Huard G.
      • Schiano T.
      • Fiel M.I.
      • Ward S.C.
      • Moon J.
      • Iyer K.
      Comparative incidence of rejection occurring in small intestinal and colonic mucosal biopsies of patients undergoing intestinal transplantation.
      A study of six colon allograft biopsies from 17 patients with colon grafts showed one case in which apoptotic injury was limited to the colon allograft; progressive injury led to explantation only of the donor colon. An additional patient showed mild acute rejection in a paired small intestinal biopsy without concordant changes in the colon allograft.
      • Cox J.
      • Merani S.
      • Grant W.J.
      • Radio S.
      • Swanson B.
      Histologic evidence for acute cellular rejection within colon allografts included during small bowel or multivisceral transplantation.
      In summary, our large cohort of colon biopsies performed for surveillance of small intestinal allografts demonstrates that almost three-quarters of these biopsies show no histological abnormality. The most common histological features observed are apoptosis and cryptitis, which could potentially raise concerns for rejection and infection, respectively. However, in all our biopsies, the apoptosis was <6 per 10 crypts and not accompanied by inflammation or crypt reactive changes, thus not supporting a diagnosis of rejection. The corresponding small intestinal biopsies, when present, did not show evidence of rejection either. However, a handful of cases were associated with concurrent infections. Cryptitis was associated with evidence of infection in blood or urine cultures in a minority of cases but was cryptogenic in the majority. It is pertinent to note that both apoptosis and cryptitis in this series of biopsies were very focal and/or mild. The presence of mild changes might further explain, along with sampling error, operator experience and patchiness of pathology, the observed discordance between endoscopic and microscopic findings. The advantage of obtaining multiple biopsies rather than a single biopsy remains to be determined. Nevertheless, in spite of the discordance, complete concordance with small intestinal biopsies suggests that colonic biopsies represent a viable modality for surveillance of small intestinal allografts. However, this statement is made with caution due to the retrospective nature of this study and lack of corresponding small intestinal biopsies in almost half of our cases.
      Crypt architectural distortion is an interesting finding in this series, which we have also observed in non-surveillance biopsies of the colon allograft. However, the number of cases is too small to allow optimal investigation or draw meaningful conclusions. This observation is worthy of detailed study as significant crypt architectural distortion, observed not infrequently in small intestinal and colon allografts, might potentially affect intestinal absorptive function.

      Conflicts of interest and sources of funding

      No conflicts of interest or funding sources to disclose.

      References

        • Lauro A.
        • Panaro F.
        • Iyer K.R.
        An overview of EU and USA intestinal transplant current activity.
        J Visc Surg. 2017; 154: 105-114
        • Grant D.
        • Abu-Elmagd K.
        • Mazariegos G.
        • et al.
        Intestinal transplant registry report: global activity and trends.
        Am J Transplant. 2015; 15: 210-219
        • Ruiz P.
        • Bagni A.
        • Brown R.
        • et al.
        Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium.
        Transplant Proc. 2004; 36: 335-337
        • Wu T.
        • Abu-Elmagd K.
        • Bond G.
        • Nalesnik M.A.
        • Randhawa P.
        • Demetris A.J.
        A schema for histologic grading of small intestine allograft acute rejection.
        Transplantation. 2003; 75: 1241-1248
        • Huard G.
        • Schiano T.
        • Fiel M.I.
        • Ward S.C.
        • Moon J.
        • Iyer K.
        Comparative incidence of rejection occurring in small intestinal and colonic mucosal biopsies of patients undergoing intestinal transplantation.
        Histopathology. 2016; 69: 600-606
        • Cox J.
        • Merani S.
        • Grant W.J.
        • Radio S.
        • Swanson B.
        Histologic evidence for acute cellular rejection within colon allografts included during small bowel or multivisceral transplantation.
        Lab Invest. 2018; 98S: 253-254